Genetics Generation Advancement Corp. (4160) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genetics Generation Advancement Corp. (4160:TWSE), powered by AI.

Current Price
$41.10
Sector
Healthcare
What is the Genetics Generation Advancement Corp. stock price forecast?

Genetics Generation Advancement Corp. is currently trading at $41.10. View real-time AI analysis on Alpha Lenz.

What is Genetics Generation Advancement Corp. insider trading activity?

View the latest insider trading data for Genetics Generation Advancement Corp. on Alpha Lenz.

What is Genetics Generation Advancement Corp.'s P/E ratio?

View Genetics Generation Advancement Corp.'s valuation metrics on Alpha Lenz.

Genetics Generation Advancement Corp.

TWSE · 4160
NT$41.10+1.05(+2.62%)
Ask about Genetics Generation Advancement Corp.'s future dividend policy...
Alpha Chat Insight

Genetics Generation Advancement Corp.'s ROE is 3.7%. Explore profitability and growth together.

Ask for details

Company Overview

Genetics Generation Advancement Corp. is a healthcare company specializing in diagnostics and genetic testing services, headquartered in Taipei, Taiwan. Its primary function is to provide a comprehensive suite of genetic and informatics testing solutions, spanning from pre-implantation and prenatal screening to newborn medical examinations, health management, and reproductive medicine assessments. The company also extends its expertise to specialized diagnostics in obstetrics, gynecology, neonatology, pediatrics, gastroenterology, hepatology, oncology, and broader medical research. In addition to testing, Genetics Generation Advancement Corp. is active in life sciences and material sciences, offering research and development management, enterprise quality management, and solutions for process production operation and digital data management systems. Established in 2008, it plays a significant role in supporting precision medicine and health technology sectors within Taiwan's healthcare industry. By integrating advanced genomics and informatics, the firm contributes to improving early disease detection, personalized treatment, and the overall advancement of biomedical research in the region.

SectorHealthcare
IndustryDiagnostics & Research
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$603.11MRevenue
0.00Shares Out
0Employees

Margins

41.52%Gross
9.03%EBITDA
2.12%Operating
4.55%Pre-Tax
3.56%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

3.26%Rev 3Yr
6.36%Rev 5Yr
-15.02%Op Inc 3Yr
N/AOp Inc 5Yr
-6.14%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

2.80%ROA
3.70%ROE
3.67%ROIC

Financial Health

NT$65.67MCash & Cash Equivalents
NT$138.38MNet Debt
33.90%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genetics Generation Advancement Corp. (ticker: 4160) is a company listed on TWSE in the Healthcare sector (Diagnostics & Research).

The current price is 41.1 with a P/E ratio of -x and P/B of -x.

ROE is 3.70% and operating margin is 2.12%. Annual revenue is $603M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genetics Generation Advancement Corp. (4160) Stock Forecast 2026 $41.10 — Price, Financials & Analyst Targets | Alpha Lenz